MedPath

Pain Control In First Trimester Medical Abortion: A Randomized Trial

Phase 4
Completed
Conditions
Pain
Interventions
Registration Number
NCT01457521
Lead Sponsor
Gynuity Health Projects
Brief Summary

This trial will compare two oral analgesic regimens in women undergoing first trimester medical abortion with mifepristone and misoprostol. The primary study outcome is pain.

Detailed Description

This trial will compare two oral analgesic regimens in women undergoing first trimester medical abortion with mifepristone and misoprostol. The primary study outcome is pain. Secondary objectives include comparing the regimens for the total amount of ibuprofen taken, use of other analgesics, vaginal bleeding, adverse events, successful completion of abortion, overall satisfaction with the abortion procedure.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
250
Inclusion Criteria
  • Pregnant women with a gestational age of 63 days or less
  • Desire a medical abortion with mifepristone and misoprostol
Exclusion Criteria
  • Have contraindications to ibuprofen

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
TherapeuticIbuprofenIbuprofen
ProphylacticIbuprofenIbuprofen
Primary Outcome Measures
NameTimeMethod
11-point Visual Analog Scale for Pain1-2 weeks

Participant pain was assessed using an 11-point Visual Analog Scale for Pain. Scores ranged from 0 (no pain) to 10 (worst pain possible)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Family Planning Associates Medical Group

🇺🇸

Chicago, Illinois, United States

Planned Parenthood of New York City, Inc.

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath